Eton Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Eton Pharmaceuticals, Inc. (ETON) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents14.9421.3916.3114.4121.3012.0726.74
Cash & Short-Term Investments14.9421.3916.3114.4121.3012.0726.74
Accounts Receivable5.363.411.855.470.050.470.00
Inventory15.230.910.560.551.240.380.00
Other Current Assets5.491.131.293.182.120.000.00
Total Current Assets41.0226.8420.0023.6024.7015.0127.50
Non-Current Assets
Property, Plant & Equipment (Net)0.210.150.260.221.001.280.77
Intangible Assets34.884.744.753.620.580.000.00
Other Non-Current Assets0.010.010.010.020.040.060.05
Total Non-Current Assets35.104.905.033.861.622.060.83
Total Assets76.1231.7425.0327.4726.3217.0728.33
Current Liabilities
Accounts Payable4.171.851.773.143.511.962.02
Short-Term Debt0.005.381.031.420.280.000.00
Current Portion of Long-Term Debt0.005.381.031.420.280.000.00
Accrued Liabilities15.788.963.661.371.170.000.00
Other Current Liabilities15.783.630.000.000.000.000.00
Total Current Liabilities19.9516.246.464.563.791.962.02
Non-Current Liabilities
Long-Term Debt29.810.025.385.286.634.560.00
Other Non-Current Liabilities1.830.000.000.000.280.000.00
Total Non-Current Liabilities31.750.025.495.287.144.560.00
Total Liabilities51.7016.2611.959.8410.666.522.02
Stockholders' Equity
Common Stock0.030.030.030.030.020.000.00
Retained Earnings-107.89-104.07-103.13-94.11-92.16-64.19-45.87
Additional Paid-in Capital132.29119.52116.19111.72107.8074.7272.15
Shares Outstanding26.7125.6925.3524.630.000.000.00
Total Stockholders' Equity24.4315.4813.0817.6315.6610.5526.30
Total Liabilities & Equity76.1231.7425.0327.4726.3217.0728.33